# Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium

> **NCT02928692** · PHASE3 · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 750 (estimated)

## Conditions studied

- Prostate Cancer
- Carcinoma of the Rectum
- Colon Cancer
- Renal Carcinoma

## Interventions

- **DRUG:** Minocycline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02928692
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2020-01-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02928692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02928692, "Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT02928692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*